Abstract:The aim of this study was to evaluate the effects of recombinant human adenovirus p53 (rAd-p53; Gendicine) transfection and radiation at various time points following transfection. Cytotoxic effects and p53 protein expression levels were analyzed. rAd-p53 containing the human wild-type p53 gene was introduced into the human lung adenocarcinoma cell line A549, and cells were irradiated with a single dose of 6 MeV 4 Gy β rays. According to the time interval between rAd-p53 transfection and radiotherapy (RT), A549-transfected rAd-p53 cells were divided into 5 groups: radiation administered immediately after transfection (0 h-RT) group, after 3 h group (3 h-RT), after 6 h group (6 h-RT), after 24 h group (24 h-RT) and after 48 h group (48 h-RT). Cells with rAd-p53 transfection alone (Ad-p53) and with empty adenovirus (Ad) were included as the two control groups. Following 72 h of transfection, cell viability and growth were analyzed using MTT assays and flow cytometry, and p53 protein expression was analyzed using western blot analysis. From 0 h-RT to 48 h-RT, cell viability gradually decreased, while percentage of apoptotic cells and p53 protein expression gradually increased. The cell viability suppression rates in the 6 h-RT, 24 h-RT and 48 h-RT groups were 56.7±5.4, 60.8±6.0 and 68.9±6.6, respectively, which were significantly greater compared to that of the Ad-p53 (40.8±4.7), 0 h-RT (45.0±3.5) and 3 h-RT groups (47.0±4.3). No statistically significant differences were observed in the cell viability suppression rates among the 6 h-RT, 24 h-RT and 48 h-RT groups (P>0.05). Similar changes were observed in the percentage of apoptotic cells. The p53 protein expression level in the 6 h-RT group (0.856±0.092) was higher compared to that in the 3 h-RT group (0.643±0.089) (t=2.882; P=0.045), but not significantly different from that of the 24 h-RT group (1.193±0.202). The cell viability suppression rate and percentage of apoptotic cells was positively correlated with p53 protein expression in the A549 cells (P<0.05). Radiation may inhibit or damage p53 protein expression at the early stage of rAd-p53 transfection. To sensitize tumor cells to irradiation and achieve maximal cytotoxic effects, it is recommended to conduct RT at least 6 h following transfection with rAd-p53.

EFFECT OF RECOMBINANT ADENOVIRUS-p53 COMBINED WITH DOCETAXEL ON THE GROWTH INHIBITION OF HUMAN LUNG ADENOCARCINOMA CELL LINES

[Effect of Recombinant Adenovirus-P53 on Growth and Chemosensitivity of Human Lung Adenocarcinoma Cell Lines].

Effects of Recombinant Adenovirus-p53 Combined with Oxaliplatin on Growth Inhibition of Human Gastric Cancer Cell Line SGC-7901

Sequence-dependent antiproliferative effects of gefitinib combined with docetaxel in non-small cell lung cancer cells in vitro

Effect of Adenovirus-mediated Wild-Type P53 Gene Transfection on the Growth and Radiosensitivity of Human Lung Adenocarcinoma Cells

Effect of Recombinant Adenovirus-P53 Combined with Oxaliplatin on the Growth Inhibition of Human Gastric Cancer Cell Line BGC-823

[Effect of Recombinant Human Adenovirus P53 Combined with Cisplatin on the Expression of Human Lung Adenocarcinoma A549 Cell Gene].

Synergistic Effects of TOR Combined with EADM on Growth and Apoptosis in Human Lung Cancer Cell Lines A549 and H1299

Effect of recombinant adenovirus-p53 combined with oxaliplatin on the growth inhibition of human colonic cancer cells

In Vitro Effect of Recombinant Human Adenovirus p53 Combined with Epirubicin on Human Gastric Cancer Cells

The Curative Effects and Side Effects of Recombinant Human Adenovirus P53 on Transplanted Gastric Cancer Cells in Nude Mice

Combination of (-)-gossypol and docetaxel for lung cancer

The effects of cetuximab in combination with docetaxel for the acquired resistance to EGFR-TKI in non-small cell lung cancer cells

Inhibitory Effects of 5-Aza-2′-deoxycytidine and Trichostatin A in Combination with P53-Expressing Adenovirus on Human Laryngocarcinoma Cells

Inhibitory Effect of Recombinant Adenovirus Encoding Human P53 Tumor Suppressor Gene(rad-P53) Combined with Radiation Therapy on Human Lymphoma Cells Lines Growth

Growth-inhibiting effects of toremifene combined with cisplatin on p53-deficient strain of human lung cancer H1299 cells

Recombinant Human Adenovirus P53 Injection Enhanced Sensitivity Of Chemotherapeutics Through Dna Damage Response Pathway In Advanced Papillary Thyroid Cancer In Vitro And In Vivo

Effect of Adenovirus-Mediated P53 Gene Transfer on Apoptosis and Radiosensitivity of Human Gastric Carcinoma Cell Lines

Effects of rAd-p53 on growth of human hepatic carcinoma cells

Synergistic Cytotoxic Effects of Recombinant Human Adenovirus P53 and Radiation at Various Time Points in A549 Lung Adenocarcinoma Cells

Combined effect of recombinant human adenovirus p53 and curcumin in the treatment of liver cancer.